Results of P-AKT assay
. | Humanized mAbs, % relative to no mAb control . | . | . | Murine mAbs, % relative to no mAb control . | . | |||
|---|---|---|---|---|---|---|---|---|
. | hL243γ4P . | hA20 . | hMN-14 . | mL243 . | mMN-14 . | |||
| Namalwa | 8.4 | –2.8 | 1.3 | 3.5 | –4.4 | |||
| FSCCL | 25.1 | –1.4 | 3.9 | 16.3 | –1.7 | |||
| Daudi | 34.9 | 1.0 | –1.4 | 24.5 | –2.1 | |||
| RL | 5.9 | 1.8 | 0.0 | 1.3 | 1.3 | |||
| SU-DHL-6 | 29.8 | 0.2 | 1.2 | 26.1 | –0.5 | |||
| Raji | 5.1 | –0.9 | –1.6 | 17.2 | –4.2 | |||
. | Humanized mAbs, % relative to no mAb control . | . | . | Murine mAbs, % relative to no mAb control . | . | |||
|---|---|---|---|---|---|---|---|---|
. | hL243γ4P . | hA20 . | hMN-14 . | mL243 . | mMN-14 . | |||
| Namalwa | 8.4 | –2.8 | 1.3 | 3.5 | –4.4 | |||
| FSCCL | 25.1 | –1.4 | 3.9 | 16.3 | –1.7 | |||
| Daudi | 34.9 | 1.0 | –1.4 | 24.5 | –2.1 | |||
| RL | 5.9 | 1.8 | 0.0 | 1.3 | 1.3 | |||
| SU-DHL-6 | 29.8 | 0.2 | 1.2 | 26.1 | –0.5 | |||
| Raji | 5.1 | –0.9 | –1.6 | 17.2 | –4.2 | |||